nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aberrant Brain Triple-Network Effective Connectivity Patterns in Type 2 Diabetes Mellitus
|
Zhang, Yujie |
|
|
15 |
5 |
p. 1215-1229 |
artikel |
2 |
Adherence and Persistence to Basal Insulin Among People with Type 2 Diabetes in Europe: A Systematic Literature Review and Meta-analysis
|
Gimeno, Esteban J. |
|
|
15 |
5 |
p. 1047-1067 |
artikel |
3 |
An Obesity-Centric Approach with and Without Anti-Obesity Medications Compared to the Usual-Care Approach to Management of Patients with Obesity and Type 2 Diabetes in an Employer Setting: A Pragmatic Randomized Controlled Trial (EMPOWER-T2D)
|
Pantalone, Kevin M. |
|
|
15 |
5 |
p. 1201-1214 |
artikel |
4 |
Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity
|
Klein, Klara R. |
|
|
15 |
5 |
p. 1169-1186 |
artikel |
5 |
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes
|
Gutgesell, Robert M. |
|
|
15 |
5 |
p. 1069-1084 |
artikel |
6 |
Effectiveness of a Lifestyle Improvement Support App in Combination with a Wearable Device in Japanese People with Type 2 Diabetes Mellitus: STEP-DM Study
|
Takahashi, Akiko |
|
|
15 |
5 |
p. 1187-1199 |
artikel |
7 |
Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study)
|
Tamanaha, Tamiko |
|
|
15 |
5 |
p. 1245-1254 |
artikel |
8 |
Efficacy and Safety of Tirzepatide in Patients with Type 2 Diabetes: Analysis of SURPASS-AP-Combo by Different Subgroups
|
Bi, Yan |
|
|
15 |
5 |
p. 1125-1137 |
artikel |
9 |
Evaluating the Safety and Efficacy of Sodium-Glucose Co-transporter 2 Inhibitors in Subjects with Prediabetes: A Protocol for a Randomized Controlled Trial
|
Zhu, Xiaxuan |
|
|
15 |
5 |
p. 1231-1244 |
artikel |
10 |
Expert Opinion on Current Trends in the Use of Insulin in the Management of People with Type 2 Diabetes from the South-Eastern European Region and Israel
|
Tabak, Adam G. |
|
|
15 |
5 |
p. 897-915 |
artikel |
11 |
Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study
|
Terui, Sakiko |
|
|
15 |
5 |
p. 1139-1153 |
artikel |
12 |
Insulin Use During Gestational and Pre-existing Diabetes in Pregnancy: A Systematic Review of Study Design
|
Castorino, Kristin |
|
|
15 |
5 |
p. 929-1045 |
artikel |
13 |
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
|
Seidu, Samuel |
|
|
15 |
5 |
p. 1099-1124 |
artikel |
14 |
Summary of Research: Efficacy and Safety of the SGLT2 Inhibitor Empagliflozin Versus Placebo and the DPP-4 Inhibitor Linagliptin Versus Placebo in Young People with Type 2 Diabetes (DINAMO): A Multicentre, Randomised, Double-Blind, Parallel Group, Phase 3 Trial
|
Laffel, Lori M. |
|
|
15 |
5 |
p. 893-896 |
artikel |
15 |
The Current and Future Role of Insulin Therapy in the Management of Type 2 Diabetes: A Narrative Review
|
McGill, Janet B. |
|
|
15 |
5 |
p. 1085-1098 |
artikel |
16 |
The Implication of Diabetes-Specialized Nurses in Aiming for the Better Treatment and Management of Patients with Diabetes Mellitus: A Brief Narrative Review
|
Zhu, Yefang |
|
|
15 |
5 |
p. 917-927 |
artikel |
17 |
Validity of Montreal Cognitive Assessment to Detect Cognitive Impairment in Individuals with Type 2 Diabetes
|
Gupta, Anu |
|
|
15 |
5 |
p. 1155-1168 |
artikel |